Physician profile
Willis G Parsons
NPI 1972578698
$152,560.82
in general payments reported to CMS, 2019-2025
34 companies · $48K in 2025
The $48K reported for 2025 was more than what 97% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $9,976 · 2021: $1,977 · 2022: $22K · 2023: $12K · 2024: $36K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Consulting Fee: $38K · Food and Beverage: $5,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,320.00 |
| Consulting Fee | $37,700.00 |
| Food and Beverage | $5,948.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $42,320.00 | 2024-2025 | Echotip Insight, Fusion |
| Fujifilm Healthcare Americas Corporation | $38,460.28 | 2022-2025 | Fujifilm |
| Cook Medical LLC | $32,797.65 | 2019-2025 | Hemospray, Fusion, D.A.S.H. |
| Wilson Cook Medical Incorporated | $21,066.43 | 2019-2023 | Fusion |
| Gi Supply, INC. | $8,277.91 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $3,488.00 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Boston Scientific Corporation | $1,153.19 | 2019-2025 | Axios, General - Biliary Devices, Exalt Model D |
| Ambu INC. | $897.98 | 2021-2023 | |
| Conmed Corporation | $664.97 | 2023-2025 | Conmed Biliary, Conmed Generators |
| Creo Medical INC. | $487.83 | 2023-2024 | Speedboat Ultraslim (Sb1l), Speedboat |
| Abbvie INC. | $359.07 | 2019-2025 | |
| Medtronic, INC. | $350.17 | 2021-2025 | Nexpowder, Bravo, Gi Genius |
| Olympus America INC. | $343.03 | 2019-2024 | Evis X1 Video System Center, Gastrointestinal Videoscope, Endoclot Sis |
| Regeneron Healthcare Solutions, INC. | $224.91 | 2022-2025 | Dupixent |
| Endogastric Solutions, INC | $217.12 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $196.90 | 2019-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.90 | 2019-2025 | Xifaxan |
| Genzyme Corporation | $155.82 | 2023-2025 | |
| Medical Device Business Services, INC. | $148.43 | 2019 | |
| Mauna Kea Technologies, INC. | $125.79 | 2019-2025 | |
| Micro-Tech Endoscopy USA, INC. | $106.56 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $103.40 | 2025 | Iqirvo |
| Braintree Laboratories, INC. | $74.35 | 2019-2023 | Sutab, Suflave |
| Steris Corporation | $66.56 | 2019 | |
| Celltrion USA INC. | $64.17 | 2025 | Vegzelma |
| Amgen INC. | $52.25 | 2025 | Uplizna |
| Phathom Pharmaceuticals, INC. | $39.17 | 2024-2025 | Voquezna |
| Janssen Biotech, INC. | $30.76 | 2019-2025 | Tremfya |
| Ucb, INC. | $25.48 | 2019 | |
| Servier Pharmaceuticals LLC | $24.89 | 2025 | |
| Covidien Lp | $23.04 | 2019 | |
| Exact Sciences Corporation | $19.51 | 2025 | Cologuard Collection Kit |
| Alfasigma USA, INC. | $14.27 | 2020 | |
| Allergan, INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willis Parsons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.